Quick Answer
Cardio Diagnostics Holdings, Inc. reported Operating Income Loss of -$6.48 million for the year ending 2025.
- Cardio Diagnostics Holdings, Inc. showed an increase of +22.5% in Operating Income Loss from 2024 to 2025.
- This data is from Cardio Diagnostics Holdings, Inc.'s annual report (Form 10-K), filed with the SEC on March 13, 2026.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 5 years of available data (2021 to 2025), Cardio Diagnostics Holdings, Inc.'s Operating Income Loss has declined by 945.1%.
- Historical annual values: Fiscal year 2025: -$6.48 million | Fiscal year 2024: -$8.37 million | Fiscal year 2023: -$7.24 million | Fiscal year 2022: -$4.55 million | Fiscal year 2021: -$620.4 thousand.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: